The FDA is working to update and modernize the drug review process by developing e-books and interactive learning content for scientific and regulatory education. This new educational content will focus on topics related to drug development and the FDA review process. The goal is to provide FDA reviewers and others involved in drug development with accessible, up-to-date training materials.